IP Library Granted Patent US 8,722,133
Granted Patent B2
US 8,722,133 · App. 12/865,632 · Granted May 13, 2014

Method for production of orally rapidly disintegrating tablet comprising imidafenacin as active ingredient

Inventors: Toshihiro Ishizaki (Shimotsuga-gun, JP); Yoshinobu Aoki (Shimotsuga-gun, JP)
Assignee: Kyorin Pharmaceutical Co., Ltd.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,722,133
App. No.
12/865,632
Granted
May 13, 2014
Kind
B2
Abstract

The present invention herein provides an imidafenacin-containing orally rapidly disintegrating tablet which is excellent in the photostability. The present invention comprises the steps of: (A) granulating imidafenacin together with starch to thus give a granulated product having an imidafenacin concentration ranging from 0.001 to 3% by mass and a starch concentration ranging from 40 to 99.999% by mass; (B) covering the granulated product prepared in the step (A) with a non-cellulosic coating agent; and (C) blending the granulated product obtained in the preceding step (B) with an excipient and a disintegrating agent and then forming the resulting mixture into a tablet according to the compression molding technique.

Claims (24)

1. A method for preparing an orally rapidly disintegrating tablet comprising:

granulating imidafenacin together with starch such that a granulated product comprising the imidafenacin having an imidafenacin concentration ranging from 0.001 to 3% by mass and the starch having a starch concentration ranging from 40 to 99.999% by mass is prepared;

covering the granulated product with a non-cellulosic coating agent such that a coated granulated product comprising the granulated product and the non-cellulosic coating agent coating the granulated product is prepared;

blending the coated granulated product with an excipient and a disintegrating agent such that a resulting mixture comprising the excipient, the disintegrating agent and the coated granulated product is prepared; and

forming the resulting mixture into a tablet according to a compression molding technique.

2. The method of claim 1 , wherein the non-cellulosic coating agent is an aminoalkyl methacrylate copolymer.

3. The method of claim 1 , wherein the non-cellulosic coating agent is aminoalkyl methacrylate copolymer E.

4. The method of claim 1 , wherein the non-cellulosic coating agent is a polyvinyl acetal diethylaminoacetate.

5. The method of claim 1 , wherein the imidafenacin concentration of the granulated product has the imidafenacin concentration ranging from 0.2 to 0.6% by mass.

6. The method of claim 1 , wherein the starch concentration of the granulated product has the starch concentration ranging from 60 to 99.999% by mass.

7. The method of claim 1 , wherein the starch concentration of the granulated product has the starch concentration ranging from 70 to 99.999% by mass.

8. The method of claim 2 , wherein the imidafenacin concentration of the granulated product has the imidafenacin concentration ranging from 0.2 to 0.6% by mass.

9. The method of claim 2 , wherein the starch concentration of the granulated product has the starch concentration ranging from 60 to 99.999% by mass.

10. The method of claim 2 , wherein the starch concentration of the granulated product has the starch concentration ranging from 70 to 99.999% by mass.

11. The method of claim 3 , wherein the imidafenacin concentration of the granulated product has the imidafenacin concentration ranging from 0.2 to 0.6% by mass.

12. The method of claim 3 , wherein the starch concentration of the granulated product has the starch concentration ranging from 60 to 99.999% by mass.

13. The method of claim 3 , wherein the starch concentration of the granulated product has the starch concentration ranging from 70 to 99.999% by mass.

14. The method of claim 4 , wherein the imidafenacin concentration of the granulated product has the imidafenacin concentration ranging from 0.2 to 0.6% by mass.

15. The method of claim 4 , wherein the starch concentration of the granulated product has the starch concentration ranging from 60 to 99.999% by mass.

16. The method of claim 4 , wherein the starch concentration of the granulated product has the starch concentration ranging from 70 to 99.999% by mass.

17. The method of claim 1 , further comprising drying the granulated product.

18. The method of claim 1 , wherein the non-cellulosic coating agent is povidone.

19. The method of claim 1 , wherein the non-cellulosic coating agent is a methacrylic acid copolymer.

20. The method of claim 1 , wherein the non-cellulosic coating agent is an ammonio-methacrylate copolymer.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 3, 2010
From: ISHIZAKI, TOSHIHIRO; AOKI, YOSHINOBU
To: KYORIN PHARMACEUTICAL CO., LTD.
Reel/Frame 024781/0367 →
Priority Claims (1)
JP 2008-020183 · Jan 31, 2008 · national
Continuity (1)
Related Publication 20100323090A1 · Dec 23, 2010